We support diagnostics developers in the design and validation of new diagnostic tests and platforms, including Point of Care Tests (POCTs)
We collaborate with industry and innovators to evaluate and improve emerging diagnostic tests and devices. Our access to world leading hospitals and extensive clinical networks, as well as our advanced diagnostic assessment methodologies, means we are uniquely positioned to support diagnostic developers.
Patients and the public are involved in most of our activities while we also host regular engagement events to disseminate our findings. Our Patient and Public Board meet regularly to review our strategy and approach and to provide input on specific projects.
We conduct research with a number of different partners, including industry, clinical groups, NIHR infrastructures, agencies and academic researchers. Being located within one of the world’s best universities, as well as a leading NHS trust, helps us to produce consistently excellent research.
he Medicines and Healthcare products Regulatory Agency (MHRA) is warning people to not use or buy Hightop HIV/AIDS Home Test Kit after seizing 114 potentially unreliable products from 2 UK based suppliers. If you believe you have used a Hightop HIV/AIDS Home Test Kit you should seek a further HIV test at your local sexual… Read more
A safer and more accurate test for Down’s syndrome is to be introduced for pregnant mothers in Wales, the Welsh Government has announced. Non-invasive prenatal testing (NIPT) will be offered from 2018. The decision by the Welsh Government follows moves in England to do the same. Public Health Minister Rebecca Evans said ministers wanted to ensure every… Read more
In 2008, the National Institute for Health Research (NIHR) created Collaborations for Leadership in Applied Health Research and Care (CLAHRCs). They have a specific aim: to bridge the gap between the world class research conducted by academics and its implementation on the NHS frontline, where it can impact on patient lives and the quality of… Read more
A study showing how rapid negative exclusion of blood cultures by a molecular method, Cognitor® Minus, can aid antimicrobial stewardship. UK study in general blood culture of 246 patients with suspected sepsis. In 74% of cases where Cognitor® Minus gave a negative result there was a positive antimicrobial stewardship outcome: – Either cessation of antibiotics… Read more
The NIHR Invention for Innovation (i4i) Programme is launching a new funding stream – i4i Connect – aimed at small and medium-sized enterprises (SMEs) in need of a funding boost to reach their next stage in the development pathway. Offering up to £150,000 over a 6-12 month period, i4i Connect will help SMEs get to… Read more
Your chance to win a free light scientific advice service worth £15,000. Are you a healthcare SME, academic research group or charity? Are you developing a transformative heathcare product for the NHS? Can your product change lives or save money? Would you like our input on your evidence development plans?… Read more
How do SMEs ensure that their innovations are safe and effective, and how can they demonstrate this to payers, practitioners, regulators and patients? DEC London attended a meeting organised by DigitalHealth.London to address these questions – and to help to connect innovative SMEs with key research and regulatory organisations, including the National Institute of Health Research (NIHR) and NICE. The conclusion was… Read more
We held our first Patient and Public Involvement (PPI) Knowledge Transfer Event at Imperial College London on Friday 17th February 2017! A short summary of this very exciting and valuable event is included below. Aim: To discuss Patient and Public Involvement and Engagement (PPI) in medical technology and in-vitro diagnostic research carried out within the National Institute for… Read more
The National Institute for Health Research (NIHR) invites you to apply for a place at this roadshow specifically tailored for medtech SMEs to find out more about: the mission, strategic priorities and activities of the NIHR opportunities for SMEs via our funding programmes* how we support SMEs in the conduct of clinical trials how we help SMEs to… Read more
The 2017 Diagnostics Summit will address how Diagnostics are supporting prevention of hospital admissions across the UK. Drawing on best-practice and expertise from key leaders at the forefront of Diagnostics research and development, the Summit will explore how Diagnostics are being implemented at community care and secondary health levels including within Laboratory’s to prevent disease… Read more
As in previous years, the conference will explore new developments in sensor technology and advances in their application in medicine and healthcare. Uniquely among a plethora of sensor conferences, Sensors in Medicine 2017 highlights those sensor developments which can improve patient outcomes. The conference will include invited and submitted papers, poster exhibits and a exhibition…. Read more
This event, held in Lisbon in April, will feature six tracks: Prenatal Molecular Diagnostics, Biomarkers for Immunotherapy, Cell-Free DNA in Clinical Oncology, Enabling Technologies for Cell-Free DNA, Advanced Diagnostics for Infectious Disease, and Point-of-Care Diagnostics…. Read more
The NIHR Diagnostics Forum is a meeting of industry, academia and healthcare professionals developing ways to facilitate the utilisation and adoption of innovative tests through good quality evidence. The forum will be held in the beautiful setting of Lady Margaret Hall, Oxford. Representatives from DEC London, and the other DECs, will be in attendance. https://www.oxford.dec.nihr.ac.uk/courses-and-events/nihr-diagnostics-forum-2017… Read more
World precision Medicine Congress – including DEC roundtable The World Precision Medicine Congress 2017 brings together academia, industry and healthcare professionals to discuss and debate key challenges and opportunities within diagnostics, and other areas relevant to precision medicine. On the Wednesday (17th May) Matt Hallsworth, NOCRI’s Head of External Relations, will host a DEC round… Read more
Talks from high profile academic and clinical experts; senior government and industry representatives; and a patient representative will highlight how the UK is leading the way in pharmacogenetics and stratified medicine. This event provides a great opportunity to meet with colleagues involved in delivering personalised medicine to patients. Chair and scientific advisor: Professor Sir Munir Pirmohamed… Read more
A full day event for the medtech sector – providing advice and guidance on the evaluation evidence required to access the NHS market. You will be able to learn about the support available to help you efficiently generate evidence on your technology. The event will be of importance to companies working on the development of… Read more